Cite
HARVARD Citation
Schweizer, M. et al. (2023). Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial. Journal of urology. 209 (2), pp. 354-363. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schweizer, M. et al. (2023). Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial. Journal of urology. 209 (2), pp. 354-363. [Online].